
Sustained growth with global expansion and strong market share

Hemant Bakshi is set to take charge as managing director and global CEO of EPL from January 2026

Strong Q2, rising exports, and expanding high-margin verticals signal enduring momentum

Though the stock debuted at a 28 percent premium, there is limited upside potential in the near term

Quarterly performance was driven by strong exports and a premium mix

Sun Pharma’s revenues from specialty drugs surpassed generic medicines for the first time in the US

The Morigaon semiconductor facility is part of a wider network of government-backed projects aimed at bolstering India’s semiconductor production capabilities

Lenskart and Groww will be listed on the secondary market. At least three new IPOs will open for subscription.

While earnings growth will align with credit growth, the stock upside will be driven by the expansion of the valuation multiple

Healthy momentum in automotive and farm segments drives growth; management upbeat on FY26 prospects

Higher-value customers, expanding digital offerings, and a strong Africa recovery fuel the telco’s growth.

Consolidation, geographical expansion and investments in specialised healthcare drove deal activity

Valuation comfort, strong operational metrics, and favourable industry tailwinds make the AMC an attractive long-term opportunity

The company is back to double-digit volume growth after five quarters

Growth in the US business slowed in recent quarters

New products and cost efficiency to support future performance


Strong distribution network, push for premium products support expansion plans

IndiGo’s market share in the domestic market increased in the last one year

The company maintained its guidance of robust growth in operating earnings in FY26.

The bank’s return ratios are healthy and the stock valuation is reasonable

Healthy order bookings are expected to improve revenue growth at LTIMindtree

Flash PMIs, China GDP, US inflation and quarterly results are the key events, data points to track

The company sustains growth momentum with record deal wins and expanding AI-driven pipeline.

The directive is similar to the one issued after India-made cough syrups were blamed for deaths of children in Gambia and Uzbekistan even as Coldrif toll climbs to 22 after two more children die